Thermosensitive nanosystems associated with hyperthermia for cancer treatment

Detalhes bibliográficos
Autor(a) principal: Isabela Pereira Gomes
Data de Publicação: 2019
Outros Autores: Jaqueline Aparecida Duarte, Ana Luiza Chaves Maia, Domenico Rubello, Danyelle M. Townsend, André Luís Branco de Barros, Elaine Amaral Leite
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UFMG
Texto Completo: https://doi.org/10.3390/ph12040171
http://hdl.handle.net/1843/56502
https://orcid.org/0000-0001-7750-036X
https://orcid.org/0000-0001-6841-3061
https://orcid.org/0000-0003-1592-7936
https://orcid.org/0000-0003-3885-9374
https://orcid.org/0000-0003-4679-1891
https://orcid.org/0000-0002-7641-6585
https://orcid.org/0000-0001-8812-3811
Resumo: Conventional chemotherapy regimens have limitations due to serious adverse effects. Targeted drug delivery systems to reduce systemic toxicity are a powerful drug development platform. Encapsulation of antitumor drug(s) in thermosensitive nanocarriers is an emerging approach with a promise to improve uptake and increase therapeutic efficacy, as they can be activated by hyperthermia selectively at the tumor site. In this review, we focus on thermosensitive nanosystems associated with hyperthermia for the treatment of cancer, in preclinical and clinical use.
id UFMG_5a5614e9cb5e885a772dcfc106c71a9d
oai_identifier_str oai:repositorio.ufmg.br:1843/56502
network_acronym_str UFMG
network_name_str Repositório Institucional da UFMG
repository_id_str
spelling Thermosensitive nanosystems associated with hyperthermia for cancer treatmentHyperthermiaThermosensitive systemsCancer treatmentCancer - TratamentoConventional chemotherapy regimens have limitations due to serious adverse effects. Targeted drug delivery systems to reduce systemic toxicity are a powerful drug development platform. Encapsulation of antitumor drug(s) in thermosensitive nanocarriers is an emerging approach with a promise to improve uptake and increase therapeutic efficacy, as they can be activated by hyperthermia selectively at the tumor site. In this review, we focus on thermosensitive nanosystems associated with hyperthermia for the treatment of cancer, in preclinical and clinical use.Universidade Federal de Minas GeraisBrasilFAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICASFAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOSUFMG2023-07-17T20:27:58Z2023-07-17T20:27:58Z2019info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.3390/ph120401711424-8247http://hdl.handle.net/1843/56502https://orcid.org/0000-0001-7750-036Xhttps://orcid.org/0000-0001-6841-3061https://orcid.org/0000-0003-1592-7936https://orcid.org/0000-0003-3885-9374https://orcid.org/0000-0003-4679-1891https://orcid.org/0000-0002-7641-6585https://orcid.org/0000-0001-8812-3811porPharmaceuticalsIsabela Pereira GomesJaqueline Aparecida DuarteAna Luiza Chaves MaiaDomenico RubelloDanyelle M. TownsendAndré Luís Branco de BarrosElaine Amaral Leiteinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMG2023-07-17T20:27:58Zoai:repositorio.ufmg.br:1843/56502Repositório InstitucionalPUBhttps://repositorio.ufmg.br/oairepositorio@ufmg.bropendoar:2023-07-17T20:27:58Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false
dc.title.none.fl_str_mv Thermosensitive nanosystems associated with hyperthermia for cancer treatment
title Thermosensitive nanosystems associated with hyperthermia for cancer treatment
spellingShingle Thermosensitive nanosystems associated with hyperthermia for cancer treatment
Isabela Pereira Gomes
Hyperthermia
Thermosensitive systems
Cancer treatment
Cancer - Tratamento
title_short Thermosensitive nanosystems associated with hyperthermia for cancer treatment
title_full Thermosensitive nanosystems associated with hyperthermia for cancer treatment
title_fullStr Thermosensitive nanosystems associated with hyperthermia for cancer treatment
title_full_unstemmed Thermosensitive nanosystems associated with hyperthermia for cancer treatment
title_sort Thermosensitive nanosystems associated with hyperthermia for cancer treatment
author Isabela Pereira Gomes
author_facet Isabela Pereira Gomes
Jaqueline Aparecida Duarte
Ana Luiza Chaves Maia
Domenico Rubello
Danyelle M. Townsend
André Luís Branco de Barros
Elaine Amaral Leite
author_role author
author2 Jaqueline Aparecida Duarte
Ana Luiza Chaves Maia
Domenico Rubello
Danyelle M. Townsend
André Luís Branco de Barros
Elaine Amaral Leite
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Isabela Pereira Gomes
Jaqueline Aparecida Duarte
Ana Luiza Chaves Maia
Domenico Rubello
Danyelle M. Townsend
André Luís Branco de Barros
Elaine Amaral Leite
dc.subject.por.fl_str_mv Hyperthermia
Thermosensitive systems
Cancer treatment
Cancer - Tratamento
topic Hyperthermia
Thermosensitive systems
Cancer treatment
Cancer - Tratamento
description Conventional chemotherapy regimens have limitations due to serious adverse effects. Targeted drug delivery systems to reduce systemic toxicity are a powerful drug development platform. Encapsulation of antitumor drug(s) in thermosensitive nanocarriers is an emerging approach with a promise to improve uptake and increase therapeutic efficacy, as they can be activated by hyperthermia selectively at the tumor site. In this review, we focus on thermosensitive nanosystems associated with hyperthermia for the treatment of cancer, in preclinical and clinical use.
publishDate 2019
dc.date.none.fl_str_mv 2019
2023-07-17T20:27:58Z
2023-07-17T20:27:58Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.3390/ph12040171
1424-8247
http://hdl.handle.net/1843/56502
https://orcid.org/0000-0001-7750-036X
https://orcid.org/0000-0001-6841-3061
https://orcid.org/0000-0003-1592-7936
https://orcid.org/0000-0003-3885-9374
https://orcid.org/0000-0003-4679-1891
https://orcid.org/0000-0002-7641-6585
https://orcid.org/0000-0001-8812-3811
url https://doi.org/10.3390/ph12040171
http://hdl.handle.net/1843/56502
https://orcid.org/0000-0001-7750-036X
https://orcid.org/0000-0001-6841-3061
https://orcid.org/0000-0003-1592-7936
https://orcid.org/0000-0003-3885-9374
https://orcid.org/0000-0003-4679-1891
https://orcid.org/0000-0002-7641-6585
https://orcid.org/0000-0001-8812-3811
identifier_str_mv 1424-8247
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Pharmaceuticals
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Minas Gerais
Brasil
FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS
FAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS
UFMG
publisher.none.fl_str_mv Universidade Federal de Minas Gerais
Brasil
FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS
FAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS
UFMG
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMG
instname:Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
instname_str Universidade Federal de Minas Gerais (UFMG)
instacron_str UFMG
institution UFMG
reponame_str Repositório Institucional da UFMG
collection Repositório Institucional da UFMG
repository.name.fl_str_mv Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)
repository.mail.fl_str_mv repositorio@ufmg.br
_version_ 1816829817216040960